Category: by publisher

Former Tokyo Tech materials researcher sanctioned after bringing forward evidence of data fabrication

A materials researcher faced three months without salary, retired from his research position and may have to return a portion of a grant worth $1 million US as punishment after a postdoc in his lab was caught fabricating data.

Seizo Miyata, formerly a materials researcher at the Tokyo Institute of Technology, headed a group that worked on carbon alloy catalysts. Last year, Miyata told Retraction Watch, he found evidence that postdoc Wu Libin had fabricated data.

Reached by Retraction Watch by phone, Miyata didn’t say who uncovered the evidence, nor how, but when he confronted Libin, the postdoc confessed. Miyata said he alerted Texas Tokyo Tech administrators last year, and requested the retraction of “Preparation of carbon-based catalysts for PEFC cathodes from aromatic polyamide with Fe compound,” which appeared in Applied Catalysis A: General in July 2011. That retraction notice reads: Continue reading Former Tokyo Tech materials researcher sanctioned after bringing forward evidence of data fabrication

20 more retractions for scientist who made up email addresses so he could review his own papers

Hyung-In Moon, the South Korean plant compound researcher who came up with fake email addresses so that he could do his own peer review, has retracted twenty more papers, all in Immunopharmacology and Immunotoxicology, an Informa Healthcare title.

Here are the papers: Continue reading 20 more retractions for scientist who made up email addresses so he could review his own papers

Ulrich Lichtenthaler’s co-author removed from paper

The Ulrich Lichtenthaler publication record continues to unravel.

Lichtenthaler has retracted six papers, and a frequent co-author’s name has been removed from a recent paper in the Journal of Product Innovation Management. The paper, “The Performance Implications of Dynamic Capabilities: The Case of Product Innovation,” went online on June 12 of this year. Its abstract now includes this note: Continue reading Ulrich Lichtenthaler’s co-author removed from paper

More shoes drop for Chinese author who made up peer reviewer addresses

Last month, we brought you the story of Guang-Zhi He of the Guiyang College of Traditional Chinese Medicine in China, an enterprising fellow who got caught faking the email addresses of potential peer reviewers. At the time, Elsevier, who published journals where He published, told us there would be several retractions other than the one we reported on.

Three of those have appeared, in the same journal, Experimental Parasitology, and saying the same thing: Continue reading More shoes drop for Chinese author who made up peer reviewer addresses

Authors retract prostate cancer-grape seed compound paper for figure presentation error

University of Alabama researchers have retracted a paper claiming that a grape skin seed compound might have anti-prostate cancer effects.

Here’s the notice for “Proanthocyanidins from grape seeds inhibit expression of matrix metalloproteinases in human prostate carcinoma cells, which is associated with the inhibition of activation of MAPK and NFκB”: Continue reading Authors retract prostate cancer-grape seed compound paper for figure presentation error

Retraction six arrives for Ulrich Lichtenthaler

Ulrich Lichtenthaler

Ulrich Lichtenthaler, who has already retracted five papers for statistical irregularities, has retracted a sixth, “The Impact of Accumulating and Reactivating Technological Experience on R&D Alliance Performance,” in the Journal of Management Studies. The notice, which was first reported by the Open Innovation Blog, reads: Continue reading Retraction six arrives for Ulrich Lichtenthaler

South Korean plant compound researcher faked email addresses so he could review his own studies

Hyung-In Moon

Scientists frustrated by the so-called “third reviewer” — the one always asking for additional experiments before recommending acceptance — might be forgiven for having fantasies of being able to review their own papers.

But one Korean scientist, Hyung-In Moon, managed to do just that, through what must have seemed like clever subterfuge at the time. And he got away with it for a while — until he didn’t, as witnessed by this retraction notice for “Larvicidal activity of 4-hydroxycoumarin derivatives against Aedes aegypti,” published in Pharmaceutical Biology, an Informa Healthcare title: Continue reading South Korean plant compound researcher faked email addresses so he could review his own studies

Retraction number five for management professor Ulrich Lichtenthaler

The retraction count for management professor Ulrich Lichtenthaler, whose work has been subject to scrutiny for statistical irregularities, is up to five. Here’s the notice for “Product business, foreign direct investment, and licensing: Examining their relationships in international technology exploitation,” in the Journal of World Business: Continue reading Retraction number five for management professor Ulrich Lichtenthaler

Duplication earns highly cited prostate cancer researcher a correction in JCO

Laurence Klotz, a prominent urologist at the University of Toronto who studies the prostate specific antigen (PSA), has corrected a paper after reusing his own words from an earlier review.

Here’s the correction, from the Journal of Clinical Oncology (JCO): Continue reading Duplication earns highly cited prostate cancer researcher a correction in JCO

Seeing red (wine): Another retraction for Dipak Das, making count 13

Today’s Retraction Watch, to paraphrase Sesame Street, is brought to you by the number 13.

Earlier, we reported on several retractions from Diederik Stapel that bring his total to that number, and now we’ve learned about number 13 for Dipak Das. Das is of course the UConn researcher who was found to have committed 145 counts of misconduct in his studies of the red wine compound resveratrol and other subjects.

Here’s the notice, from The Journal of Nutritional Biochemistry, for “Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose:” Continue reading Seeing red (wine): Another retraction for Dipak Das, making count 13